Literature DB >> 21899349

Synthesis, structure, and biological activity of dumbbell-shaped nanocircular RNAs for RNA interference.

Naoko Abe1, Hiroshi Abe, Chisato Nagai, Mitsuru Harada, Hiroto Hatakeyama, Hideyoshi Harashima, Takahito Ohshiro, Mizuki Nishihara, Kazuhiro Furukawa, Mizuo Maeda, Satoshi Tsuneda, Yoshihiro Ito.   

Abstract

RNA interference (RNAi) is one of the most promising new approaches for disease therapy. The design of a dumbbell-shaped nanocircular RNA allows it to act as a short interfering RNA (siRNA) precursor. To optimize the design, we studied the relationship between the nanostructure and RNAi activity by synthesizing various RNA dumbbells. An RNA dumbbell with a 23-bp stem and 9-nt loops was the most potent. Sequence analysis by mass spectrometry showed that Dicer could edit RNA dumbbells to siRNA species. The reaction offered the slow release of siRNA species, which conferred prolonged RNAi activity. Introduction of DNA into the loop position significantly stabilized the dumbbell in biological fluid without any loss of RNAi activity. In-depth pharmacological evaluation was performed by introducing dumbbells into HeLa cells that stably express the target luciferase gene. The dumbbells provided a rapid silencing effect and retained this effect for a longer time even at a lower concentration than that at which standard siRNA completely lost RNAi activity. We conclude that an RNA dumbbell with DNA loops is the most promising design for in vivo applications for RNA medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21899349     DOI: 10.1021/bc2003154

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  14 in total

1.  Pseudorotaxane formation via the slippage process with chemically cyclized oligonucleotides.

Authors:  Kazumitsu Onizuka; Tomoko Chikuni; Takuya Amemiya; Takuya Miyashita; Kyoko Onizuka; Hiroshi Abe; Fumi Nagatsugi
Journal:  Nucleic Acids Res       Date:  2017-05-19       Impact factor: 16.971

2.  SMEpred workbench: A web server for predicting efficacy of chemicallymodified siRNAs.

Authors:  Showkat Ahmad Dar; Amit Kumar Gupta; Anamika Thakur; Manoj Kumar
Journal:  RNA Biol       Date:  2016-09-07       Impact factor: 4.652

Review 3.  In vitro circularization of RNA.

Authors:  Sabine Müller; Bettina Appel
Journal:  RNA Biol       Date:  2016-09-26       Impact factor: 4.652

4.  Identification and characterization of circular RNAs in the silkworm midgut following Bombyx mori cytoplasmic polyhedrosis virus infection.

Authors:  Xiaolong Hu; Min Zhu; Xing Zhang; Bo Liu; Zi Liang; Lixu Huang; Jian Xu; Lei Yu; Kun Li; Mian Sahib Zar; Renyu Xue; Guangli Cao; Chengliang Gong
Journal:  RNA Biol       Date:  2017-12-21       Impact factor: 4.652

5.  Preferential production of RNA rings by T4 RNA ligase 2 without any splint through rational design of precursor strand.

Authors:  Hui Chen; Kai Cheng; Xiaoli Liu; Ran An; Makoto Komiyama; Xingguo Liang
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

6.  Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.

Authors:  Jesper B Bramsen; Jørgen Kjems
Journal:  Front Genet       Date:  2012-08-20       Impact factor: 4.599

Review 7.  RNA circularization strategies in vivo and in vitro.

Authors:  Sonja Petkovic; Sabine Müller
Journal:  Nucleic Acids Res       Date:  2015-02-06       Impact factor: 16.971

Review 8.  Functional nanostructures for effective delivery of small interfering RNA therapeutics.

Authors:  Cheol Am Hong; Yoon Sung Nam
Journal:  Theranostics       Date:  2014-09-19       Impact factor: 11.556

9.  Generation of siRNA Nanosheets for Efficient RNA Interference.

Authors:  Hyejin Kim; Jae Sung Lee; Jong Bum Lee
Journal:  Sci Rep       Date:  2016-04-28       Impact factor: 4.379

Review 10.  Noncoding RNA therapeutics - challenges and potential solutions.

Authors:  Melanie Winkle; Sherien M El-Daly; Muller Fabbri; George A Calin
Journal:  Nat Rev Drug Discov       Date:  2021-06-18       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.